🇺🇸 FDA
Pipeline program

FMP1/AS02A

WRAIR 1029

Phase 1 mab completed

Quick answer

FMP1/AS02A for Malaria is a Phase 1 program (mab) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
United Therapeutics Europe Ltd
Indication
Malaria
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials